Velarion · Company Intelligence
Compensation Brief
Fiscal year 2025 · Filings through 2026-07-06

Definitive Healthcare (DH)

Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$8,604,138
Kevin Coop total, FY2025
65th
CEO pay percentile vs peers
CEO-to-median pay ratio
89.55%
Say-on-pay support, latest vote
Companies that benchmark against DH
6 companies name DH as a compensation peer

Each company listed discloses DH in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named DH in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

01

Summary Compensation Table — fiscal year 2025

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Kevin Coop$500,000$0$7,696,741$0$384,875$0$22,522$8,604,138
Chief Executive Officer
Casey Heller362,30803,451,6220146,078014,2283,974,236
Chief Financial Officer
Benjamin Graboske318,36620,0002,881,8740185,120011,7753,417,135
EVP Technology and Engineering, Chief Data Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY20242025
Kevin Coop$8,604,138$10,876,456−2,272,318
Casey Heller3,974,236
Benjamin Graboske3,417,135

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

02

Equity transactions since the proxy statement was filed

Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Jason KrantzDirector2026-05-01D12,166$1$12,044CommonForm 4 ↗
Casey HellerChief Financial Officer2026-05-01D1,46911,454CommonForm 4 ↗
Kevin CoopDirector2026-06-01D66,050165,390CommonForm 4 ↗
Casey HellerChief Financial Officer2026-06-01D164,3771162,733CommonForm 4 ↗
Scott StephensonDirector2026-06-04A189,19000CommonForm 4 ↗
Samuel A. HamoodDirector2026-06-04A189,19000CommonForm 4 ↗
Sastry ChilukuriDirector2026-06-04A189,19000CommonForm 4 ↗
Kathleen WintersDirector2026-06-04A189,19000CommonForm 4 ↗
Jonathan ParisChief Legal Officer2026-07-01D30,591124,473CommonForm 4 ↗
Kevin CoopDirector2026-07-01D37,593130,074CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

03

Grants of plan-based awards — fiscal year 2025

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
Kevin CoopPRSU$7,696,741
Casey HellerPRSU3,451,622
Benjamin GraboskePRSU2,881,874
03b

Vehicle mix — grant-date fair value by award type

Grant-level vehicle detail not disclosed.

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

04

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Kevin CoopRSU2,382,892$6,838,900
Kevin CoopPSU1,283,0963,682,486
Casey HellerPSU261,628750,872
Kevin CoopRSU128,007367,380
Casey HellerRSU18,08851,913
Casey HellerRSU498,3391,430,233
Kevin CoopRSU804,4082,308,651
Kevin CoopPSU1,137,0383,263,299
Casey HellerRSU485,8811,394,478
Casey HellerRSU11,16632,046
Casey HellerRSU28,28181,166
05

Incentive-plan design — the Compensation Discussion & Analysis

Definitive Healthcare s executive compensation philosophy is based on total direct compensation--base salary, annual cash incentives, and long-term equity incentives--designed to attract and retain executive talent, reward achievement of financial and strategic objectives, and align executives interests with stockholders. The HCM & Compensation Committee oversees this program using its judgment, considers peer/market data and CEO recommendations (other than for the CEO), and generally seeks a mix in which long-term equity represents a substantial majority of target compensation.

CEO STI target (% of salary)100%
CEO LTI target (% of salary)
Independent consultant
Clawback policyTrue
Anti-hedgingtrue
Anti-pledgingtrue
06

Say-on-pay — recent advisory votes

Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20262026-06-04108,811,27112,680,71919,22389.55%Passed
20252025-06-05108,597,11112,910,917167,62489.25%Passed
20242024-05-22141,376,7633,663,2028,34697.47%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

Meeting yearMeeting dateApproval — company's computation
20262026-06-0489.55%a
20252025-06-0589.25%b
20242024-05-2297.47%c

a. Approved under the standard stated in the filing — “2), you may vote "FOR," "AGAINST," or "ABSTAIN." Abstentions will have the same effect as a vote "AGAINST" Proposal No.”.

b. Approved under the standard stated in the filing — “2), you may vote "FOR," "AGAINST," or "ABSTAIN." Abstentions will have the same effect as a vote "AGAINST" Proposal No.”.

c. Approved under the standard stated in the filing — “2), you may vote "FOR," "AGAINST," or "ABSTAIN." Abstentions will have the same effect as a vote "AGAINST" Proposal No.”.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

07

CEO pay ratio

Ratio (CEO : median employee)
CEO total compensation
Median employee compensation
08

Director compensation — fiscal year 2025

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Jason KrantzEmployee director · Board Chair$477,614$0$61,371$538,985
Kathleen WintersIndependent · Audit175,000199,04300374,043
Sastry ChilukuriIndependent · Audit · Nominating and Corporate Governance175,000199,04300374,043
Jill LarsenIndependent · HCM and Compensation (Chair) · Departed during FY70,000199,04300269,043
Samuel A. HamoodIndependent · Audit (Chair)70,000199,04300269,043
Scott StephensonIndependent · HCM and Compensation (Chair) · Nominating and Corporate Governance53,913199,04300252,956
Christopher EganNot independent000000
Kevin CoopEmployee director00000
Jeff HaywoodIndependent · HCM and Compensation000000
Lauren YoungIndependent · HCM and Compensation · Nominating and Corporate Governance (Chair)000000
09

Board fee structure and ownership guideline

Annual cash retainer$50,000
Annual equity retainer$175,000
Per board meeting fee
Committee chair fees (audit / comp / nom-gov)20,000 / 20,000 / 10,000
Stock ownership guideline$150,000
09b

Total cost of the board

ComponentFY2025
Cash retainers and fees$543,913
Equity awards (grant-date value)$1,472,829
All other compensation$61,371
Total cost of the board$2,078,113

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Definitive Healthcare2025Kevin Coop$500,000$7,696,741$0$384,875$8,604,138

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Kevin CoopDEF 14A2026-04-230001193125-26-173661Section “Summary Compensation Table” · page 26. As printed: 8,604,138. Filing ↗machine: t17 · r2 · c26 · span 499241–499250
2Section 01, Casey HellerDEF 14A2026-04-230001193125-26-173661Section “Summary Compensation Table” · page 26. As printed: 3,974,236. Filing ↗machine: r4 · c26 · span 519054–519063
3Section 01, Benjamin GraboskeDEF 14A2026-04-230001193125-26-173661Section “Summary Compensation Table” · page 26. As printed: 3,417,135. Filing ↗machine: r6 · c26 · span 538870–538879
4Section 03, Kevin Coop PRSUDEF 14A2026-04-230001193125-26-173661Section “E XECUTIVE COMPENSATION TABLES” · grants of plan-based awards table. Filing ↗machine: t17 · r2 · c14 · span 495103–495112
5Section 03, Casey Heller PRSUDEF 14A2026-04-230001193125-26-173661Section “E XECUTIVE COMPENSATION TABLES” · grants of plan-based awards table. Filing ↗machine: t17 · r4 · c14 · span 514922–514931
6Section 03, Benjamin Graboske PRSUDEF 14A2026-04-230001193125-26-173661Section “E XECUTIVE COMPENSATION TABLES” · grants of plan-based awards table. Filing ↗machine: t17 · r6 · c14 · span 534732–534741
7Section 07, pay ratio10-K2026-02-260001193125-26-076782Section “CEO Pay Ratio”. As printed: —. Filing ↗
8Section 08, Jason KrantzDEF 14A2026-04-230001193125-26-173661Section “Director Compensation”. As printed: 538,985. Filing ↗machine: t27 · r5 · c15 · span 1012016–1012023
9Section 08, Kathleen WintersDEF 14A2026-04-230001193125-26-173661Section “Director Compensation”. As printed: 374,043. Filing ↗machine: t27 · r8 · c15 · span 1030462–1030469
10Section 08, Sastry ChilukuriDEF 14A2026-04-230001193125-26-173661Section “Director Compensation”. As printed: 374,043. Filing ↗machine: t27 · r9 · c15 · span 1036615–1036622
11Section 08, Jill LarsenDEF 14A2026-04-230001193125-26-173661Section “Director Compensation”. As printed: 269,043. Filing ↗machine: t27 · r6 · c15 · span 1018162–1018169
12Section 08, Samuel A. HamoodDEF 14A2026-04-230001193125-26-173661Section “Director Compensation”. As printed: 269,043. Filing ↗machine: t27 · r3 · c15 · span 999718–999725
13Section 08, Scott StephensonDEF 14A2026-04-230001193125-26-173661Section “Director Compensation”. As printed: 252,956. Filing ↗machine: t27 · r10 · c15 · span 1042767–1042774
14Section 08, Christopher EganDEF 14A2026-04-230001193125-26-173661Section “Director Compensation”. As printed: 0. Filing ↗machine: t27 · r2 · c11 · span 992029–992030
15Section 08, Kevin CoopDEF 14A2026-04-230001193125-26-173661Section “Director Compensation”. As printed: 0. Filing ↗
16Section 08, Jeff HaywoodDEF 14A2026-04-230001193125-26-173661Section “Director Compensation”. As printed: 0. Filing ↗machine: t27 · r4 · c11 · span 1004328–1004329
17Section 08, Lauren YoungDEF 14A2026-04-230001193125-26-173661Section “Director Compensation”. As printed: 0. Filing ↗machine: t27 · r7 · c11 · span 1022772–1022773
18Section 02, Jason Krantz 2026-05-01Form 42026-05-050001193125-26-206353Insider equity transaction reported since the proxy statement. Filing ↗
19Section 02, Casey Heller 2026-05-01Form 42026-05-050001193125-26-206349Insider equity transaction reported since the proxy statement. Filing ↗
20Section 02, Kevin Coop 2026-06-01Form 42026-06-030001193125-26-255405Insider equity transaction reported since the proxy statement. Filing ↗
21Section 02, Casey Heller 2026-06-01Form 42026-06-030001193125-26-255409Insider equity transaction reported since the proxy statement. Filing ↗
22Section 02, Scott Stephenson 2026-06-04Form 42026-06-080001193125-26-262529Insider equity transaction reported since the proxy statement. Filing ↗
23Section 02, Samuel A. Hamood 2026-06-04Form 42026-06-090001193125-26-263150Insider equity transaction reported since the proxy statement. Filing ↗
24Section 02, Sastry Chilukuri 2026-06-04Form 42026-06-080001193125-26-261833Insider equity transaction reported since the proxy statement. Filing ↗
25Section 02, Kathleen Winters 2026-06-04Form 42026-06-080001193125-26-261948Insider equity transaction reported since the proxy statement. Filing ↗
26Section 02, Jonathan Paris 2026-07-01Form 42026-07-060001193125-26-296167Insider equity transaction reported since the proxy statement. Filing ↗
27Section 02, Kevin Coop 2026-07-01Form 42026-07-060001193125-26-296168Insider equity transaction reported since the proxy statement. Filing ↗
28Section 06, 2026 voteForm 8-K2026-06-050001193125-26-259530Item 5.07 · say-on-pay result. As reported: 89.55% (votes for as printed: 108,811,271). Filing ↗
29Section 06, 2025 voteForm 8-K2025-06-060000950170-25-083070Item 5.07 · say-on-pay result. As reported: 89.25% (votes for as printed: 108,597,111). Filing ↗
30Section 06, 2024 voteForm 8-K2024-05-240000950170-24-064571Item 5.07 · say-on-pay result. As reported: 97.47% (votes for as printed: 141,376,763). Filing ↗
31Section 01 trend, Δ column (computed)ComputedcomputedΔ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1)
32Section 09b board cost (computed)ComputedcomputedCash 543,913 + equity 1,472,829 + all other 61,371 = 2,078,113, summed across the director compensation table rows.machine: formula: Σ = 2,078,113
33Definitive Healthcare (subject), Section 10b CEO totalDEF 14A2026-04-230001193125-26-173661CEO total compensation as printed in Definitive Healthcare's own proxy. As printed: 8,604,138. Filing ↗machine: t17 · r2 · c26 · span 499241–499250